BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2413069)

  • 1. A new model of experimental auto-immune myasthenia gravis.
    Souan ML; Geffard M
    J Neuroimmunol; 1985 Oct; 9(6):327-38. PubMed ID: 2413069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML; Geffard M
    Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of passively transferred experimental myasthenia with anti-idiotypic antibodies.
    Souroujon MC; Pachner AR; Fuchs S
    Neurology; 1986 May; 36(5):622-5. PubMed ID: 3703261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of the acetylcholine receptor.
    Lennon VA
    Immunol Commun; 1976; 5(4):323-44. PubMed ID: 61167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-acetylcholine antibodies and the pathogenesis of myasthenia gravis.
    Souan ML; Geffard M; Vieillemaringe J; Lebrun-Grandie P; Orgogozo JM
    Ann N Y Acad Sci; 1987; 505():423-38. PubMed ID: 3479933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The auto-anti-idiotypic route to antireceptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS
    Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune regulation of experimental myasthenia.
    Fuchs S; Bartfeld D; Eshhar Z; Feingold C; Mochly-Rosen D; Novick D; Schwartz M; Tarrab-Hazdai R
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):634-43. PubMed ID: 7400824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental autoimmune myasthenia gravis.
    Lindstrom J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):568-76. PubMed ID: 6249892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Sarangarajan R; Rajagopalan R; Cayanis E; Edelman IS; Penn AS
    Immunol Rev; 1986 Dec; 94():23-37. PubMed ID: 3492425
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
    Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
    Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-acetylcholine and anti-receptor antibodies in myasthenia].
    Lebrun-Grandie P; Souan ML; Geffard M; Dartigues JF; Mauricet B; Orgogozo JM
    Presse Med; 1987 Oct; 16(32):1577-80. PubMed ID: 2958833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis.
    Wassermann NH; Penn AS; Freimuth PI; Treptow N; Wentzel S; Cleveland WL; Erlanger BF
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4810-4. PubMed ID: 6181515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; De Baets MH
    Adv Neuroimmunol; 1994; 4(4):457-74. PubMed ID: 7719618
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.
    Barkas T; Simpson JA
    Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis.
    Zurn AD; Fulpius BW
    Eur J Immunol; 1977 Aug; 7(8):529-32. PubMed ID: 902680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis. Current concepts.
    Gutmann L; Chou SM
    Arch Pathol Lab Med; 1976 Aug; 100(8):401-4. PubMed ID: 947303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.